Table II.
Characteristic | Study patients | All patients |
---|---|---|
Patients (n) | 32 | 45 |
Race (%) | ||
White | 38 | 40 |
Black | 62 | 60 |
Stage (%) | ||
iib | 12 | 9 |
iiia | 19 | 29 |
iiib | 53 | 51 |
iiic | 16 | 11 |
Histology (%) | ||
Ductal | 72 | 75 |
Lobular | 6 | 9 |
Inflammatory | 22 | 16 |
Hormone receptor (%) | ||
er+/pr+ | 19 | 18 |
er+/pr− | 25 | 27 |
er−/pr+ | 3 | 2 |
er−/pr− | 53 | 53 |
her2/neu (%) | ||
Positive | 28 | 27 |
Negative | 72 | 73 |
er = estrogen receptor; pr = progesterone receptor; her2/neu = human epidermal growth factor 2.